Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Apr 27;10(4):e0125020.
doi: 10.1371/journal.pone.0125020. eCollection 2015.

The impact of smoking on airflow limitation in subjects with history of asthma and inactive tuberculosis

Hyun Jung Kim  1 , Seunghee Baek  2 , Hee Jin Kim  3 , Jae Seung Lee  4 , Yeon-Mok Oh  4 , Sang-Do Lee  4 , Sei Won Lee  4
Affiliations

The impact of smoking on airflow limitation in subjects with history of asthma and inactive tuberculosis

Hyun Jung Kim et al. PLoS One. .

Abstract

Background: Although smoking is the most important and modifiable cause of chronic obstructive pulmonary disease (COPD), other risk factors including asthma and tuberculosis (TB) are also associated. It is common for COPD patients to have more than one of these risk factors. The aims of this study were to determine the prevalence of airflow limitation (FEV1/FVC<0.7) according to the risk factors and to investigate their impact and interaction in airflow limitation.

Methods: From the Korean National Health and Nutrition Examination Survey between 2008 and 2012, we analyzed participants over 40 years of age by spirometry, chest radiograph and questionnaire about asthma and smoking history.

Results: Of 12,631 participants, 1,548 (12.3%) had airflow limitation. The prevalence of airflow limitation in smokers (≥10 pack-year), asthmatics, and those with inactive TB was 23.9%, 32.1%, and 33.6%. The prevalence increased with the number of risk factors: 86.1% had airflow limitation if they had all three risk factors. Impacts of inactive TB and asthma on airflow limitation were equivalent to 47 and 69 pack-years of smoking, respectively. Airflow limitation resulted from lower levels of smoking in those with inactive TB and asthma. A potential interaction between smoking and inactive tuberculosis in the development of airflow limitation was identified (p = 0.054).

Conclusions: Asthma and inactive TB lesions increase susceptibility to smoking in the development of airflow limitation. People with these risk factors should be seen as a major target population for anti-smoking campaigns to prevent COPD.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Flow diagram of study participants.
KNHANES = Korean National Health and Nutrition Examination Survey.
Fig 2
Fig 2. The prevalence of airflow limitation according to participant characteristics.
Smoking is defined as ≥ 10 pack-years. Airflow limitation is defined as FEV1/FVC < 0.7. *Participants with smoking history less than 10 pack-years and without inactive TB and asthma.
Fig 3
Fig 3. Development of airflow limitation according to smoking history and underlying disease.
(A) Plots of FEV1/FVC according to smoking intensity and its 50th percentile prediction line show lower levels of smoking are required for airflow limitation in participants with asthma or inactive TB than in those without. (B, C) FEV1 was lower in participants with asthma or inactive TB than in those without. The gray region represents the 95% confidence interval of FEV1. FVC = forced vital capacity, FEV1 = forced expiratory volume in one second.
Fig 4
Fig 4. The impact of inactive TB on airflow limitation according to smoking history.
The gray region represents the 95% confidence interval of the odds ratios. PY = pack-years.
See this image and copyright information in PMC

References

    1. Mannino DM, Buist AS (2007) Global burden of COPD: risk factors, prevalence, and future trends. Lancet 370: 765–773. - PubMed
    1. Mathers CD, Loncar D (2006) Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 3: e442 - PMC - PubMed
    1. Murray CJ, Lopez AD, Black R, Mathers CD, Shibuya K, Ezzati M, et al. (2007) Global burden of disease 2005: call for collaborators. Lancet 370: 109–110. - PubMed
    1. National Herat Lung and Blood Institue (2004) Morbidity and mortality: chartbook on cardiovascular, lung, and blood diesases Bethesda: US Department of Health and Human Services. Public Health Service, National Institutes of Health.
    1. Global Institute for Chronic Obstructive Lung Disease (2013) Global strategy for diagnosis, management, and prevention of COPD. Geneva.

Publication types

MeSH terms